Why the study?
Maintenance of sinus rhythm is superior to the incidence of AF in patients with rheumatic valve disease undergoing MVR surgery, prompting evaluation of prophylactic amiodarone and magnesium sulfate.
Does a prophylactic combination of intravenous amiodarone and magnesium sulfate reduce the incidence of postoperative atrial fibrillation in patients with rheumatic valve disease undergoing mitral valve replacement surgery?
Does a prophylactic combination of intravenous amiodarone and magnesium sulfate reduce the incidence of postoperative atrial fibrillation in patients with rheumatic valve disease undergoing mitral valve replacement surgery?
A single intraoperative dose of intravenous amiodarone and magnesium sulfate significantly reduces the incidence of postoperative atrial fibrillation in patients undergoing mitral valve replacement for rheumatic valve disease.
Answers are grounded in this paper and cite their sources.
Supports combined amiodarone-magnesium prophylaxis to reduce postoperative AF after mitral valve replacement; extends evidence to rheumatic valve disease.
Context: Maintenance of sinus rhythm is superior to the incidence of atrial fibrillation (AF) in patients with rheumatic valve disease undergoing mitral valve replacement (MVR) surgery. Aim: To evaluate the effect of prophylactic combination of intravenous (i.v.) amiodarone and magnesium sulfate (MgSO4) in patients undergoing MVR surgery. Materials and Methods: One hundred and twenty patients with valvular heart disease with or without AF were randomly divided into two groups. Group I (n = 60) received amiodarone (3 mg.kg−1 in 20 mL saline) + MgSO4 (30 mg.kg− 1 in 20 mL saline), and Group II (n = 60) received 40 mL of normal saline. The standardized protocol for cardiopulmonary bypass was maintained for all the patients. Statistical Analysis: Continuous variables were expressed as mean ± standard deviation and categorical variables were summarized as frequencies and percentages. Student's independent t-test was employed for comparing continuous variables. Chi-square test was applied for comparing categorical variables. Results: Before surgery, AF was observed in 58.3% of patients in Group I and in 53.3% of patients in Group II (P = 0.581). Postoperatively, in the intensive care unit, 26.7% of the patients in Group I and 71.7% in Group II had AF (P < 0.001). At the time of discharge, 30% of patients in Group I and 73.3% of patients in Group II had AF (P < 0.001). Conclusion: A single combined prophylactic intraoperative dose of i.v. amiodarone and MgSO4 decreased postbypass arrhythmia in comparison to the placebo group in patients of MVR surgery.
No takes yet. Share an insight, caveat, or question.
Angral et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: